Our study in a PCa tumor xenograft model demonstrated impaired tumor angiogenesis with PAK1 or PAK6 gene knockdown, with PAK1 suppression exhibiting a superior anti-angiogenic effect than PAK6 suppression [55]. The gene discussed is PAK1; the disease is neoplasm.